ATOS WKN: A411MH ISIN: FR001400X2S4 Forum: Aktien Thema: Hauptdiskussion
Our recent successes attest to our ability to innovate and meet our clients’ needs. In cybersecurity, we won a major contract with the NTT group in Japan for one of the world’s largest IGA (Identity Governance and Administration) projects, to enhance cybersecurity and identity governance for all its employees. Additionally, we were chosen by EUROCONTROL to continue supporting its critical airspace and aviation management services in Europe. In AI and cloud, we launched the Global GenAI Innovation Studio with AWS to accelerate business transformation through AI. In HPC, we inaugurated the AI supercomputer “Gefion” in Denmark, one of the most powerful in the world, illustrating our ability to offer leading solutions combining HPC and AI. https://atos.net/wp-content/uploads/2025/01/atos-meeting-brochure-ag-01-2025-en.pdf
Mehr zu diesem Wert
|
|
Thema | ||
|---|---|---|---|
| 1 | ATOS Hauptdiskussion | ||
| 2 | Atos | ||
| 3 | Atos Aktie kurz vorm RS. Übersicht neutral | ||
| 4 | Themen rund um ATOS | ||
| 5 | Pusher |
|
|
Thema | ||
|---|---|---|---|
| 1 | OTL nach dem RS 1:20 | +6,09 % | |
| 2 | Dax Prognose | +0,46 % | |
| 3 | VONOVIA Hauptdiskussion | -1,32 % | |
| 4 | Novo Nordisk nach Split | +4,18 % | |
| 5 | Nio für normale Kommunikation | -0,48 % | |
| 6 | Security der nächsten Generation | +1,77 % | |
| 7 | Investmentchancen | +0,59 % | |
| 8 | ZALANDO Hauptdiskussion | +3,87 % | |
| 9 | SpaceX-Haupt-Hauptforum | +0,44 % | |
| 10 | Ast Space Mobile | +4,26 % | Alle Diskussionen |
|
|
Thema | ||
|---|---|---|---|
| 1 | OTL nach dem RS 1:20 | +6,09 % | |
| 2 | Novo Nordisk nach Split | +4,18 % | |
| 3 | VONOVIA Hauptdiskussion | -1,32 % | |
| 4 | Nio für normale Kommunikation | -0,48 % | |
| 5 | Investmentchancen | +0,59 % | |
| 6 | Security der nächsten Generation | +1,77 % | |
| 7 | ZALANDO Hauptdiskussion | +3,87 % | |
| 8 | SpaceX-Haupt-Hauptforum | +2,02 % | |
| 9 | Ast Space Mobile | +4,26 % | |
| 10 | Kay Thirty-Three | +8,00 % | Alle Diskussionen |